Paul Erbel - Publications

Affiliations: 
2000-2004 Biochemistry University of Texas Southwestern Medical Center, Dallas, TX, United States 

7/16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Colbert CL, Wu Q, Erbel PJ, Gardner KH, Deisenhofer J. Mechanism of substrate specificity in Bacillus subtilis ResA, a thioredoxin-like protein involved in cytochrome c maturation. Proceedings of the National Academy of Sciences of the United States of America. 103: 4410-5. PMID 16537372 DOI: 10.1073/Pnas.0600552103  0.492
2005 Card PB, Erbel PJA, Gardner KH. Structural basis of ARNT PAS-B dimerization: Use of a common beta-sheet interface for hetero- and homodimerization Journal of Molecular Biology. 353: 664-677. PMID 16181639 DOI: 10.1016/J.Jmb.2005.08.043  0.582
2005 Yang J, Zhang L, Erbel PJA, Gardner KH, Ding K, Garcia JA, Bruick RK. Functions of the Per/ARNT/Sim domains of the hypoxia-inducible factor Journal of Biological Chemistry. 280: 36047-36054. PMID 16129688 DOI: 10.1074/Jbc.M501755200  0.68
2004 Erbel PJ, Seidel R, Macintosh SE, Gentile LN, Amor JC, Kahn RA, Prestegard JH, McIntosh LP, Gardner KH. Cyclic enterobacterial common antigen: potential contaminant of bacterially expressed protein preparations. Journal of Biomolecular Nmr. 29: 199-204. PMID 15014233 DOI: 10.1023/B:Jnmr.0000019252.65073.24  0.442
2003 Erbel PJ, Card PB, Karakuzu O, Bruick RK, Gardner KH. Structural basis for PAS domain heterodimerization in the basic helix--loop--helix-PAS transcription factor hypoxia-inducible factor. Proceedings of the National Academy of Sciences of the United States of America. 100: 15504-9. PMID 14668441 DOI: 10.1073/Pnas.2533374100  0.586
2003 Erbel PJ, Barr K, Gao N, Gerwig GJ, Rick PD, Gardner KH. Identification and biosynthesis of cyclic enterobacterial common antigen in Escherichia coli. Journal of Bacteriology. 185: 1995-2004. PMID 12618464 DOI: 10.1128/Jb.185.6.1995-2004.2003  0.44
2002 Erbel PJ, Haseley SR, Kamerling JP, Vliegenthart JF. Studies on the relevance of the glycan at Asn-52 of the alpha-subunit of human chorionic gonadotropin in the alphabeta dimer. The Biochemical Journal. 364: 485-95. PMID 12023892 DOI: 10.1042/BJ20011482  0.436
Low-probability matches (unlikely to be authored by this person)
2019 Quancard J, Klein T, Fung SY, Renatus M, Hughes N, Israël L, Priatel JJ, Kang S, Blank MA, Viner RI, Blank J, Schlapbach A, Erbel P, Kizhakkedathu J, Villard F, et al. An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient. Nature Chemical Biology. PMID 30692685 DOI: 10.1038/S41589-018-0222-1  0.273
2016 Altmann E, Erbel P, Renatus M, Schaefer M, Schlierf A, Druet A, Kieffer L, Sorge M, Pfister K, Hassiepen U, Jones M, Ruedisser S, Ostermeier D, Martoglio B, Jefferson AB, et al. Azaindoles as Zinc-Binding Small-Molecule Inhibitors of the JAMM Protease CSN5. Angewandte Chemie (International Ed. in English). PMID 27981705 DOI: 10.1002/anie.201608672  0.234
2018 Vulpetti A, Ostermann N, Randl S, Yoon T, Mac Sweeney A, Cumin F, Lorthiois E, Rüdisser S, Erbel P, Maibaum J. Discovery and Design of First Benzylamine-Based Ligands Binding to an Unlocked Conformation of the Complement Factor D. Acs Medicinal Chemistry Letters. 9: 490-495. PMID 29795765 DOI: 10.1021/acsmedchemlett.8b00104  0.209
2006 Erbel P, Schiering N, D'Arcy A, Renatus M, Kroemer M, Lim SP, Yin Z, Keller TH, Vasudevan SG, Hommel U. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus Nature Structural and Molecular Biology. 13: 372-373. PMID 16532006 DOI: 10.1038/nsmb1073  0.196
2017 Vulpetti A, Randl S, Rüdisser S, Ostermann N, Erbel P, MacSweeney A, Zoller T, Salem B, Gerhartz B, Cumin F, Hommel U, Dalvit C, Lorthiois E, Maibaum J. Structure-based library design and fragment screening for the identification of reversible complement Factor D protease inhibitors. Journal of Medicinal Chemistry. PMID 28157311 DOI: 10.1021/acs.jmedchem.6b01684  0.172
2016 Maibaum J, Liao SM, Vulpetti A, Ostermann N, Randl S, Rüdisser S, Lorthiois E, Erbel P, Kinzel B, Kolb FA, Barbieri S, Wagner J, Durand C, Fettis K, Dussauge S, et al. Small-molecule factor D inhibitors targeting the alternative complement pathway. Nature Chemical Biology. PMID 27775713 DOI: 10.1038/nchembio.2208  0.161
2014 Mac Sweeney A, Grosche P, Ellis D, Combrink K, Erbel P, Hughes N, Sirockin F, Melkko S, Bernardi A, Ramage P, Jarousse N, Altmann E. Discovery and structure-based optimization of adenain inhibitors. Acs Medicinal Chemistry Letters. 5: 937-41. PMID 25147618 DOI: 10.1021/Ml500224T  0.099
2015 Grosche P, Sirockin F, Mac Sweeney A, Ramage P, Erbel P, Melkko S, Bernardi A, Hughes N, Ellis D, Combrink KD, Jarousse N, Altmann E. Structure-based design and optimization of potent inhibitors of the adenoviral protease. Bioorganic & Medicinal Chemistry Letters. 25: 438-43. PMID 25571794 DOI: 10.1016/J.Bmcl.2014.12.057  0.094
2006 D'Arcy A, Chaillet M, Schiering N, Villard F, Lim SP, Lefeuvre P, Erbel P. Purification and crystallization of dengue and West Nile virus NS2B-NS3 complexes Acta Crystallographica Section F: Structural Biology and Crystallization Communications. 62: 157-162. PMID 16511290 DOI: 10.1107/S1744309106001199  0.061
Hide low-probability matches.